Abstract CT115: A first-in-human phase I study of CTX-712 in patients with advanced, relapsed or refractory malignant tumors (CTX-712-CL-01 study): Efficacy and safety in a hematologic malignancies cohort
Yokoyama, Hisayuki, Fukuhara, Noriko, Ando, Koji, Iida, Hiroatsu, Yamauchi, Takahiro, Fukuhara, Suguru, Izutsu, Koji, Tanoue, Yasushi, Yamamoto, Maki, Tozaki, Hirokazu, Takahara, Eiji, Shoji, Shingo, Mizutani, Akio, Morishita, Daisuke, Oda, Robert W., Miyake, Hiroshi, Yamamoto, Noboru
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article
Abstract CT110: A first-in-human phase I study of CTX-712 in patients with advanced, relapsed or refractory malignant tumors (CTX-712-CL-01 study): Efficacy and safety in solid tumor cohorts
Yamamoto, Noboru, Koyama, Takafumi, Katsuya, Yuki, Sato, Jun, Shimizu, Toshio, Tanoue, Yasushi, Yamamoto, Maki, Tozaki, Hirokazu, Takahara, Eiji, Shoji, Shingo, Mizutani, Akio, Morishita, Daisuke, Oda, Robert W., Miyake, Hiroshi, Yonemori, Kan
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article